SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
Location: Spain, Catalonia, Barcelona
Employees: 11-50
Total raised: $56.903731M
Investors 3
| Date | Name | Website |
| - | Asabys Par... | asabys.com... |
| - | Ysios Capi... | ysioscapit... |
| 05.08.2021 | Caixa Capi... | caixacapit... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 21.02.2022 | Series A | $56.903731... | Asabys Par... | webcapital... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 17.10.2023 | As Pfizer slashes revenue projections, Moderna says it “rema... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 15.06.2023 | The Global Startup Ecosystem Report 2023 shows a year of cha... | The Global Startup Ecosystem Report 2023 (GSER 2023) launched today in Amsterdam. Authored by Start... | tech.eu/20... |
| 16.11.2022 | SpliceBio recibe el premio a la “Serie A del año” en los Eur... | 16/11/2022 Nota de prensa SPLICEBIO RECIBE EL PREMIO A LA “SERIE A DEL AÑO” EN LOS EUROPEAN LIFEST... | webcapital... |
| 06.09.2022 | The 21 most promising healthtech startups of 2022, according... | Ali Ansary, the CEO of Ozette; Ashwini Zenooz, the CEO of Commure; Lucia Huang, the CEO of Osmind; a... | businessin... |
| 21.02.2022 | SpliceBio Raises €50M in Series A Financing | SpliceBio, a Barcelona, Spain-based biotechnology company exploiting Protein Splicing to develop gen... | finsmes.co... |
| 17.02.2022 | SpliceBio Raises EUR 50M in oversubscribed Series A financin... | SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene thera... | startupsre... |
| 16.02.2022 | SpliceBio raises €50M Series A round co-lead by UCB Ventures... | 16/02/2022 Nota de prensa SPLICEBIO RAISES €50M IN OVERSUBSCRIBED SERIES A FINANCING TO ADVANCE PR... | webcapital... |
| 16.02.2022 | Solution to big gene therapy obstacle leads to Spain’s large... | Gene therapy has a capacity problem. The engineered viruses used to deliver these therapies have lim... | medcitynew... |
| 21.01.2021 | Splice Bio, participada por Asabys Partners, nombra a Jean-P... | 21/01/2021 Nota de prensa SPLICE BIO, PARTICIPADA POR ASABYS PARTNERS, NOMBRA A JEAN-PHILIPPE COMB... | webcapital... |
| - | Solution to big gene therapy obstacle leads to Spain’s large... | Gene therapy has a capacity problem. The engineered viruses used to deliver these therapies have lim... | medcitynew... |